Filing Flows › Cannapharmarx (CPMD) › Q1 2025
Cannapharmarx (CPMD) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 16, 2025
Cannapharmarx (CPMD) reported revenue of $335K for the first quarter 2025 (Q1 2025), up 13-fold from a year earlier and -30% from the quarter before. Operating margin was -202.1%, net loss $691K (206.0% of revenue).
Cannapharmarx, Q1 2025: revenue $335K (13× year over year), operating margin -202.1%, net loss $691K, operating cash flow −$601K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $335K | -30% | 13× |
| Operating profit | −$678K | — | — |
| Net earnings | −$691K | — | — |
| Operating cash flow | −$601K | — | — |
What changed
Revenue was $335K in Q1 2025, up 1198% year over year and down 30% from the previous quarter.
Operating costs exceeded revenue by $678K, an operating margin of -202.1%. Total costs grew 24% against revenue growth of 1198%. The fastest-growing cost line was Cost of revenue (+81%). The quarter ended with a net loss of $691K, narrower than the previous quarter's $3.7M loss.
Operating cash flow was −$601K. Working capital and other items added $89K.
Questions
What was Cannapharmarx's revenue in the first quarter 2025?
Cannapharmarx (CPMD) reported revenue of $335K for the first quarter 2025 (Q1 2025), up 13-fold from a year earlier and -30% from the quarter before.
Was Cannapharmarx profitable in the first quarter 2025?
Operating loss was $678K (-202.1% of revenue) and net loss $691K.
Source: Cannapharmarx 10-Q on SEC EDGAR.